etanidazole has been researched along with Prostatic Neoplasms in 5 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "RTOG Protocol 90-20 was designed to evaluate the effect of the hypoxic cell sensitizer Etanidazole (SR-2508) on locally advanced adenocarcinoma of the prostate treated with concurrent external beam irradiation." | 5.08 | Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20). ( Buzydlowski, JW; Coleman, CN; DelRowe, JD; Forman, JD; Lawton, CA; Marcial, VA; Rotman, M, 1996) |
| "Fifty eight previously untreated patients with locally advanced adenocarcinoma of the prostate were entered on a Phase II trial of etanidazole (ETA) combined with standard external beam radiation therapy." | 5.07 | Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer. ( Beard, C; Buswell, L; Coleman, CN; Johnson, D; Noll, L; Rose, MA, 1994) |
| " The secondary goal was to prospectively evaluate the utility of pharmacokinetic monitoring and dose-modification of the incidence and severity of the dose-limiting peripheral neurotoxicity." | 2.67 | The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer. ( Buswell, L; Coleman, CN; Noll, L; Riese, N; Rose, MA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoff, MN | 1 |
| Yapp, DT | 1 |
| Yung, AC | 1 |
| Oliver, TS | 1 |
| Kozlowski, P | 1 |
| Beard, C | 2 |
| Buswell, L | 3 |
| Rose, MA | 2 |
| Noll, L | 2 |
| Johnson, D | 1 |
| Coleman, CN | 3 |
| Watkins-Bruner, D | 1 |
| Scott, C | 1 |
| Lawton, C | 1 |
| DelRowe, J | 1 |
| Rotman, M | 2 |
| Cella, D | 1 |
| Lawton, CA | 1 |
| Buzydlowski, JW | 1 |
| Forman, JD | 1 |
| Marcial, VA | 1 |
| DelRowe, JD | 1 |
| Riese, N | 1 |
4 trials available for etanidazole and Prostatic Neoplasms
| Article | Year |
|---|---|
Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer.
Topics: Adenocarcinoma; Etanidazole; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms | 1994 |
RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Data Collection; Etanidazole; Feasibility Studies; Follow-Up Studies; Humans; | 1995 |
Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Etanidazole; Humans; Male; Middle Aged; Neoplasm Staging; P | 1996 |
The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
Topics: Adenocarcinoma; Combined Modality Therapy; Drug Evaluation; Etanidazole; Humans; Male; Nitroimidazol | 1992 |
1 other study available for etanidazole and Prostatic Neoplasms
| Article | Year |
|---|---|
In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
Topics: Animals; Cell Hypoxia; Disease Models, Animal; Etanidazole; Female; Fluorine Radioisotopes; Hydrocar | 2008 |